Ask AI
ProCE Banner Activity

CE

Advances in Personalized TKI Therapy for CP-CML: Nursing Considerations to Enhance Patient Education, Tolerability, and Adherence

Video

Watch this on-demand webcast to explore the latest evidence and best practices for optimizing TKI therapy in chronic phase chronic myeloid leukemia (CP-CML), including individualized treatment selection and sequencing, molecular monitoring, and shared decision-making. Viewers will also examine practical strategies to improve treatment adherence and persistence and proactively identify and manage TKI-related adverse events.

Nurse Practitioners/Nurses: 0.75 Nursing contact hour, including 0.75 hour of pharmacotherapy credit

Released: September 09, 2026

Expiration: March 08, 2027

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Target Audience

This activity has been designed to meet the educational needs of oncology nurses and other healthcare professionals who care for patients with CML.

Program Learning Goal

This activity aims to improve learners’ knowledge and competence in the nursing management of patients with CP-CML who are receiving or eligible for TKI therapy. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Support shared decision-making by educating patients with CP-CML about the latest clinical evidence and regulatory approvals for TKIs that are most likely to meet their treatment goals

  • Apply evidence-based strategies for supportive care and dose optimization to manage TKI-related adverse events in patients with CP-CML

  • Identify patients with CP-CML at risk for suboptimal adherence/persistence to their TKI therapy 

Financial Disclosures

Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Colleen Malinow, MSN, NP-C: consultant/advisor/speaker: Dava Oncology.

The planners and content peer reviewers from Decera Clinical Education do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from September 09, 2026, through March 08, 2027:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Additional Disclosures

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hour, including 0.75 contact hour of pharmacotherapy credit.

ILNA Recertification Points

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas:

  • HSCT and Cellular Therapy Process and Administration (TCTCN) - 0.25*
  • Oncology Nursing Practice (OCN) - 0.25*
  • Symptom Management, Palliative Care, Supportive Care (OCN, CPHON, AOCNP) - 0.25*
  • Treatment (AOCNP, CBCN, CPHON, OCN, ROCN) - 1.0*

Total Points: 1.0*

*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of ILNA points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing.